Cymra has been granted permits from the Office of Drug Control for cultivation and manufacture on its site in the Northern Rivers of NSW
The permit allows Cymra to grow commercial crops for sale to licensed parties as well as extract cannabis to produce oils.
This is a big milestone for the team based on 3 years of waiting from the ODC.
“We are excited to bring our genetics, flower and API to the Australian market” our CEO Joel Hardy says excitedly. “This has been a lot of hard work from our Operations team, construction and management team”.
We let you focus on cultivation, whilst reducing risk and cost
Let us provide you with clean high health starter stock, when you need it. We can provide it to you at a fixed cost and fixed time while you focus on the growing and maximising your yield and financial return.
We can supply you your genetics or ours, as mothers or clones
The benefit of Tissue Culture is its ability to save very valuable space in a propagation facility while at the same time producing far superior plants to traditional Vegetative Cuttings. As Tissue Culture is undertaken at a micro level in 1 sqm you can fit thousands of plants which every 4 weeks will produce thousands and thousands of new plants.
In a traditional vegetative cuttings program a mother plant can take up 1 sqm and only produce 100 cuttings every month. In addition you require expensive lights and greenhouse temperature control systems to maintain a good environment for mother plants to be grown. The higher cost of maintaining mother plants in the Cannabis industry brings the cost of Tissue Culture down compared to Vegetative cuttings.
Secondly, if you are a a greenhouse grower it’s much more efficient to use every square metre and very staff member you have for cultivating flower, for maximum yield. Purchasing in your Tissue Culture also means you don’t have to worry about managing enough cuttings for every growth cycle that are healthy to fill each room at the right time allowing a cultivator to focus on cultivating rather than breeding new genetics, managing cutting programs.